Bates & Company |
Retirement Plan Documents Specialist Loren D. Stark Company |
Retirement, LLC |
Pentegra |
Retirement, LLC |
Jr Retirement Plan Administrator/ Administrative Assistant Hochheiser Deutsch & Co, Inc. |
Carpenter Morse Group |
Employee Benefits and Executive Compensation Associate Attorney Verrill |
Trucker Huss, A Professional Corporation |
Retirement Plan Administrator (TPA) Retirement Plan Consultants |
Compass Retirement Consulting Group, Inc. |
Retirement Plan Legal Specialist Pentegra |
Retirement Plan Relationship Manager ERISA Services, Inc. |
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
| |
<< Previous news item | Next news item >>
Thinking About Drug Price Controls Steven Pearlstein in The Washington Post; subscription may be required ![]() May 27, 2004 Excerpt: Washington Post columnist Steven Pearlstein was online to talk about whether the government should study the cost-effectiveness of new medicines and then use that information to determine how much Medicare should pay drugmakers. In his column today, Pearlstein concludes: 'The question isn't whether we'll ration and manage, but who will do it and how. And sooner we start talking about it openly, the better things will turn out.' |
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above). |
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified). |